Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Biodeal Pharmaceuticals
Acquired Company
Biological E
NalagarhIndiaBiotechnologyHealth CarepharmaceuticalsManufacturingBiotechnologyHealth CareDescription
Biodeal Pharmaceuticals has acquired a sterile injectable manufacturing facility from Biological E Limited in Paonta Sahib, India. This strategic acquisition expands Biodeal's capacity and capabilities in sterile injectables for global markets. The facility enhances Biodeal’s manufacturing footprint and regulatory credentials. The acquisition is part of Biological E's investment in its vaccine R&D campus in Telangana.
Fundz sees it the moment Biodeal Pharmaceuticals makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Biological E?
Biological E was acquired by Biodeal Pharmaceuticals, based in Nalagarh. The deal was reported on September 30, 2026. Biodeal Pharmaceuticals is focused on delivering innovative solutions in the healthcare and pharmaceuticals sector. With a commitment to excellence, the company aims to drive growth and enhance patient outcomes. Biodeal Pharmaceuticals is privately held and operates in Biotechnology.
When did Biodeal Pharmaceuticals acquire Biological E?
Biodeal Pharmaceuticals's acquisition of Biological E was reported on September 30, 2026. Biodeal Pharmaceuticals has acquired a sterile injectable manufacturing facility from Biological E Limited in Paonta Sahib, India. This strategic acquisition expands Biodeal's capacity and capabilities in sterile injectables for global markets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biological E do?
Biological E is a prominent Indian vaccine and pharmaceutical company focused on developing and manufacturing vaccines. They are known for their advanced manufacturing capabilities and commitment to public health. It is privately held, operating in Manufacturing, and is based in India.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.